Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Palbociclib effective in ER-positive endometrial cancer Next Article
Treatment of newly diagnosed ovarian cancer »
« Palbociclib effective in ER-positive endometrial cancer Next Article
Treatment of newly diagnosed ovarian cancer »
Table of Contents: ESMO 2020
Featured articles
COVID-19 and Cancer
Breast Cancer
Gastrointestinal Cancers
Lung Cancer
Melanoma
Genitourinary Cancers
Bladder cancer risk and early detection
Gynaecological Cancers
Basic Science
Related Articles
November 25, 2020
Neoadjuvant treatment in patients with high-risk early breast cancer
November 25, 2020
Adjuvant osimertinib in NSCLC reduces risk of CNS recurrence
November 25, 2020
Treatment of recurrent ovarian cancer
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy